BioSpace News Archive

Bloom Burton & Co. Inc. announces that, today, it and its affiliate acquired 1,453,070 common shares (Shares) and 6,636,734 compensation options (Compensation Options) of Satellos Bioscience Inc. (Corporation) in connection with a public offering of the Corporation by way of a short form prospectus dated May 9, 2023.

Evofem Biosciences, Inc., announced a 1-for-125 reverse stock split of the Company’s common stock, which was approved by the stockholders of the Company at the special meeting of stockholders held on March 15, 2023.

AIDS Healthcare Foundation supports an appeal by Médecins Sans Frontières urging Abbott Laboratories and Becton Dickinson to continue production of equipment and consumables for point-of-care CD4 machines. Both companies have announced that they will phase out the production of cartridges and devices over the coming years, including Abbott’s Pima CD4 analyzers, which AHF widely uses around the world.